Efficient expansion of HIV-1-specific T cell responses by homologous immunization with recombinant Semliki Forest virus particles. (Q40397362)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098555%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Efficient expansion of HIV-1-specific T cell responses by homologous immunization with recombinant Semliki Forest virus particles (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098555%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

0 references

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098555%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Peter Liljeström

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098555%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Maria Sundbäck

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098555%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Iyadh Douagi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098555%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Cecilia Dayaraj

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098555%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Mattias N E Forsell

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098555%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Eva K L Nordström

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098555%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Karin Spångberg

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098555%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Linda Tjäder

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098555%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Eivor Bonin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098555%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Magnus Sundström

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098555%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Gunilla B Karlsson Hedestam

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098555%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

English

0 references

publication date

10 August 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098555%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098555%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

341

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098555%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098555%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

190-202

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098555%20AND%20SRC:MED&resulttype=core&format=json

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Viral escape from dominant simian immunodeficiency virus epitope-specific cytotoxic T lymphocytes in DNA-vaccinated rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

HIV vaccine design and the neutralizing antibody problem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Venezuelan equine encephalitis virus vectors expressing HIV-1 proteins: vector design strategies for improved vaccine efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Heterologous human immunodeficiency virus type 1 priming-boosting immunization strategies involving replication-defective adenovirus and poxvirus vaccine vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Alphavirus replicon particles as candidate HIV vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Induction of primary virus-cross-reactive human immunodeficiency virus type 1-neutralizing antibodies in small animals by using an alphavirus-derived in vivo expression system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Recombinant Semliki Forest virus particles encoding the prME or NS1 proteins of louping ill virus protect mice from lethal challenge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Robust recall and long-term memory T-cell responses induced by prime-boost regimens with heterologous live viral vectors expressing human immunodeficiency virus type 1 Gag and Env proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Requirement of diverse T-helper responses elicited by HIV vaccines: induction of highly targeted humoral and CTL responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Vaccine protection from CD4+ T-cell loss caused by simian immunodeficiency virus (SIV) mac251 is afforded by sequential immunization with three unrelated vaccine vectors encoding multiple SIV antigens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Characterization of molecular features, antigen-binding, and in vitro properties of IgG and IgM variants of 4E10, an anti-HIV type 1 neutralizing monoclonal antibody.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

A new generation of animal cell expression vectors based on the Semliki Forest virus replicon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

A single injection of recombinant measles virus vaccines expressing human immunodeficiency virus (HIV) type 1 clade B envelope glycoproteins induces neutralizing antibodies and cellular immune responses to HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Defining the Protective Antibody Response for HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

7 January 2021

HIV vaccines 1983-2003.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

T-cell-mediated protective efficacy of a systemic vaccine approach in cynomolgus monkeys after SIV mucosal challenge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Qualitative T-helper responses to multiple viral antigens correlate with vaccine-induced immunity to simian/human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

A recombinant Semliki Forest virus particle vaccine encoding the prME and NS1 proteins of louping ill virus is effective in a sheep challenge model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

7 January 2021

HIV vaccine strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Avipox-based simian immunodeficiency virus (SIV) vaccines elicit a high frequency of SIV-specific CD4+ and CD8+ T-cell responses in vaccinia-experienced SIVmac251-infected macaques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Enhanced simian immunodeficiency virus-specific immune responses in macaques induced by priming with recombinant Semliki Forest virus and boosting with modified vaccinia virus Ankara.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-existing anti-vector immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

A significantly improved Semliki Forest virus expression system based on translation enhancer segments from the viral capsid gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Purification, Characterization, and Immunogenicity of a Soluble Trimeric Envelope Protein Containing a Partial Deletion of the V2 Loop Derived from SF162, an R5-Tropic Human Immunodeficiency Virus Type 1 Isolate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Neutralizing antibody responses to HIV: role in protective immunity and challenges for vaccine design.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Strong cellular and humoral anti-HIV Env immune responses induced by a heterologous rhabdoviral prime–boost approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Human immunodeficiency virus type 1 Gag-specific vaginal immunity and protection after local immunizations with sindbis virus-based replicon particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

inferred from DOI database lookup

7 January 2021

based on heuristic

In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: the small 6,000-molecular-weight membrane protein modulates virus release

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017

inferred from DOI database lookup

7 January 2021

based on heuristic

Two-helper RNA system for production of recombinant Semliki forest virus particles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.017